Viewing nowDonghwa Metformin Extended-Release 500mg (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

MFDS item code 202002030 · Approved 2020.03.24 · Insurance code 642706840
Treatment of type 2 diabetes mellitus in adults
This medication is used in the treatment of adult patients with type 2 diabetes whose blood sugar control is insufficient with diet and exercise alone, especially in overweight diabetic patients. It can be used alone or in combination with other oral hypoglycemic agents or insulin, effectively helping patients to control their blood sugar levels. It is a medication that supports improved blood glucose management.
The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. - The usual initial dose is one 500mg extended-release metformin hydrochloride tablet once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase it by 500mg each week. Up to a maximum of 2000mg per day may be taken with the evening meal. If glycemic control is not achieved with a maximum of 2000mg once daily, consider administering 1000mg twice daily, with both doses taken with meals. - For patients already being treated with metformin tablets, the initial dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At treatment initiation and during dose adjustment, fasting blood glucose should be measured to assess response to this medicine and determine the minimum effective dose. Blood glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be closely monitored every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, respectively, this medicine must be discontinued immediately.
This medication can rarely cause a serious condition known as lactic acidosis, which can be life-threatening, so caution is needed. When used with other diabetes medications, hypoglycemia may occur, so blood sugar levels should be closely monitored. This medication should not be used in patients with moderate to severe renal impairment or those with acute conditions such as dehydration, severe infections, or myocardial infarction. In patients with acute heart failure or before and after examinations using radiological contrast agents, administration of this medication should be suspended, and renal function must be checked before re-administration. Patients who have had an allergic reaction to this medication, patients with type 1 diabetes, and patients with metabolic acidosis should not be administered this medication. In cases of severe infection, trauma, or before and after surgery, administration should be temporarily suspended and resumed when the patient's condition stabilizes. Caution is necessary in patients with poor nutritional status, weak liver function, or those who consume excessive alcohol. This medication may cause side effects such as gastrointestinal disturbances, taste disturbances, and vitamin B12 deficiency, particularly gastrointestinal symptoms are common during initial treatment but improve over time. Renal function should be monitored regularly, and if renal function declines, this medication should be stopped. If blood sugar control becomes difficult or if symptoms of hypoglycemia appear, consultation with a physician is required. The hypoglycemic effect may vary depending on other medications taken concurrently, so patients should inform healthcare professionals of any medications they are taking. During pregnancy, it may affect the fetus, so if there are plans to become pregnant or if already pregnant, consultation with a physician is essential. During breastfeeding, this medication may be excreted in breast milk, so the breastfeeding status and medication treatment should be managed accordingly. It is preferable not to use this medication in children as safety has not been established. In elderly patients, dose adjustment may be necessary according to renal function decline, and regular monitoring of renal function is vital. In the case of overdose, the risk of lactic acidosis is greater than the risk of hypoglycemia, so appropriate treatment should be sought immediately. This medication helps control blood sugar levels without weight gain, and it should be swallowed whole; it is normal for the tablet shell to be excreted, so do not worry about it. Keep out of reach of children and do not transfer to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius (room temperature).
White, double convex rectangular extended-release tablet
Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.